EUTM file information

018406376

ONCOTYPE MAP


February 22, 2021

Trademark Summary

The trademark application ONCOTYPE MAP was filed by Genomic Health, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 14, 2021, and it was registered by office on June 21, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 42 with Laboratory research in the field of cancer research and disease classification and providing laboratory research services in the field of genetic testing, including next-generation sequencing (ngs), namely, cancer biology..
  • The mark was filed in class 44 with following description of goods:
    1. Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification
    2. Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification
    3. Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics
    4. Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer.
Trademarkers